A Trial to Improve Quality of Life in People With Cirrhosis
Status:
Not yet recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
This trial is being completed to evaluate whether a crystallized form of lactulose
(Kristalose) will improve quality of life, sleep and cognitive function in patients with
cirrhosis that have not been diagnosed with Hepatic Encephalopathy (HE), but report reduced
quality of life.